US OptionsDetailed Quotes

IMUX250117P4500

Watchlist

0.00
0.000.00%

15min DelayTrading Jan 10 09:30 ET

0.00High0.00Low

Immunic Stock Discussion

Jaguar8

Jan 7 07:29

NEWS

$Immunic (IMUX.US)$
Immunic Highlights 2024 Accomplishments and Upcoming Milestones
Tuesday, 7th January at 6:30 am
– Top-Line Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis Expected in April –
– Reported Positive Outcome from Interim Analysis of Ongoing, Twin Phase 3 ENSURE Trials of Vidofludimus Calcium in Relapsing Multiple Sclerosis; Both Trials on Track to Be Completed in 2026 –
– Strengthened Management Team and Board of Directors with Key Hir...

SJ66Pegasus

Dec 20, 2024 07:46

$Immunic (IMUX.US)$ https://www.sec.gov/edgar/search/#/ciks=0001280776&entityName=IMMUNIC%252C%2520INC.%2520(IMUX)%2520(CIK%25200001280776)
Anything Important?

SJ66Pegasus

Dec 20, 2024 05:31

$Immunic (IMUX.US)$ 20.6% of IMUX 's stock were hold by retail investors (Institutional hold 62.16%, and Indiser hold 17.24% . Insider buying ,not much,yet still buying.Anyway Indiser can disguised in any form, we just think like them,and play predator instead.

SJ66Pegasus

Dec 20, 2024 04:40

$Immunic (IMUX.US)$ Scam Huge Scam

71261076

Dec 17, 2024 16:49

$Immunic (IMUX.US)$ The issue is they really have no product with final data while competitors move in with therapies that are FDA approved. The market for MS has many approved therapies. With each therapy approved, there is no immediate need for another one. Typically, this extends the approval time period. Even if data is very positive May of 2025 it will take 6 to 12 months for FDA to approve. So you will not see any real significant moves on this until 2026. By that time, they will need more...